首页> 美国卫生研究院文献>Frontiers in Endocrinology >The Effects of DPP-4 Inhibitors GLP-1RAs and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism

【2h】

The Effects of DPP-4 Inhibitors GLP-1RAs and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism

机译：DPP-4抑制剂GLP-1RAS和SGLT-2/1抑制剂对糖尿病患者心力衰竭历史记录的影响：CVOTS和药物机制的见解

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Frontiers in Endocrinology
作者
Xiaohui Pan; Shishi Xu; Juan Li; Nanwei Tong;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类情报学;
关键词

机译：2型糖尿病;降血糖剂;心力衰竭;心血管效益;心血管结果试验;

相似文献

外文文献
中文文献
专利

1. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose?: Findings from the SHIFT (Systolic Heart failure treatment with the I f inhibitor ivabradine Trial) study [J] . SwedbergK., KomajdaM., B?hmM., Journal of the American College of Cardiology . 2012,第22期

机译：依伐布雷定对充血性心力衰竭患者心率降低结局的影响：β-受体阻滞剂剂量是否有影响？：SHIFT（使用If抑制剂依伐布雷定试验进行收缩性心力衰竭治疗）的研究结果
2. Effects of the DPP-4 Inhibitor Linagliptin on Heart Failure Outcomes in Patients With Type 2 Diabetes and Cardio-Renal Disease in CARMELINA [J] . McGuire Darren K. K., Alexander John H., Perkovic Vlado, Circulation: An Official Journal of the American Heart Association . 2018,第25期

机译：DPP-4抑制剂LINAGLIPTIN对CARMELINA型糖尿病患者心力衰竭结果的影响
3. Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome and Cardiac Function in Patients With Diabetes and Heart Failure　― Insights From the Ibaraki Cardiac Assessment Study-Heart Failure (ICAS-HF) Registry ― [J] . Masayoshi Yamamoto, Yoshihiro Seo, Tomoko Ishizu, Circulation journal . 2017,第11期

机译：二肽肽肽酶-4抑制剂对糖尿病和心力衰竭患者心血管结果和心脏功能的影响 - 从拔牙诊断研究 - 心力衰竭（ICA-HF）登记 -
4. Clinical characteristics, management, and outcomes of patients with high risk chronic heart failure referred to a heart failure clinic in Saudi Arabia [C] . Waleed M.A. World Congress on Heart Disease. . 2013

机译：高危慢性心力衰竭患者的临床特征，管理和结果提及沙特阿拉伯的心力衰竭诊所
5. Adherence to practice guidelines and heart failure patient outcomes before and after implementation of the HEARTFELT (HEART Failure Effectiveness and Leadership Team) intervention. [D] . Dykes, Patricia C. 2004

机译：在实施HEARTFELT（心力衰竭有效性和领导力团队）干预措施前后，都要遵守实践准则和心力衰竭患者的预后。
6. Letter by Taegtmeyer and Karlstaedt Regarding Article LowerRisk of Heart Failure and Death in Patients Initiated on Sodium-GlucoseCotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REALStudy (Comparative Effectiveness of Cardiovascular Outcomes in New Users ofSodium-Glucose Cotransporter-2 Inhibitors) [O] . Heinrich Taegtmeyer, Anja Karlstaedt -1

机译：Taegtmeyer和Karlstaedt关于以下文章的信函：服用钠葡萄糖的患者发生心力衰竭和死亡的风险Cotransporter-2抑制剂与其他降糖药：CVD-REAL研究（心血管结局新使用者的心血管效果比较效果）钠葡萄糖共转运蛋白2抑制剂）
7. The Effects of DPP-4 Inhibitors, GLP-1RAs, and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism [O] . Xiaohui Pan, Shishi Xu, Juan Li, 2020

机译：DPP-4抑制剂，GLP-1RAS和SGLT-2/1抑制剂对糖尿病患者心力衰竭历史记录的影响：CVOTS和药物机制的见解

The Effects of DPP-4 Inhibitors GLP-1RAs and SGLT-2/1 Inhibitors on Heart Failure Outcomes in Diabetic Patients With and Without Heart Failure History: Insights From CVOTs and Drug Mechanism

著录项

相似文献

相关主题

期刊订阅